Skip to content

Research to practice an ideal screening model for complication of diabetes in India

RCUK Project: SMART INDIA (Statistical Modelling and Risk Assessment of Type 2 diabetes Complications in India) Study - SMART India

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/08/015568
Enrollment
120000
Registered
2018-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Evaluating house screening to detect Diabetic Retinopathy: Evaluating house screening to detect Diabetic Retinopathy

Sponsors

Moorfields Eye Hospital NHS Trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adults who are > 40 years of age (special community groups also will contain only adult population) Ability to give informed consent Local residents of indian origin

Exclusion criteria

Exclusion criteria: Subjects who do not have the ability to give consent Vulnerable adults in whom it may not be possible to carry out all tests Pregnant and breast feeding women Anyone in the opinion of the health worker deemed too ill to be screened. Current participation in intervention trials with investigational medicinal products

Design outcomes

Primary

MeasureTime frame
To evaluate the diagnostic accuracy of various tests (Table 4) that can diagnose prediabetes and diabetes, retinopathy and a combination of both microvascular and macrovascular complications to be used as screening models for holistic screening for diabetes and its complicationsTimepoint: The screening is aimed to be completed in 18 to 36 months.

Secondary

MeasureTime frame
1)Evaluate the clinical and cost-effectiveness of various models including the trade-offs of using an economically viable model compared to an ideal model. 2)Perform further statistical modelling to refine stratification and risk prediction 3)A process evaluation will be done in accordance with the MRC guidance and Re-aim theoretical frameworkTimepoint: The screening is aimed to be completed in 18 to 36 months.

Countries

India, United Kingdom

Contacts

Public ContactDr Rajiv Raman

Sankara Nethralaya

rajivpgraman@gmail.com9444288708

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026